Capital World Investors’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-8,002,700
| Closed | -$30M | – | 579 |
|
2021
Q4 | $30M | Hold |
8,002,700
| – | – | ﹤0.01% | 502 |
|
2021
Q3 | $41.4M | Hold |
8,002,700
| – | – | 0.01% | 474 |
|
2021
Q2 | $34.1M | Hold |
8,002,700
| – | – | 0.01% | 489 |
|
2021
Q1 | $42.5M | Hold |
8,002,700
| – | – | 0.01% | 453 |
|
2020
Q4 | $43.1M | Hold |
8,002,700
| – | – | 0.01% | 427 |
|
2020
Q3 | $63.9M | Hold |
8,002,700
| – | – | 0.01% | 371 |
|
2020
Q2 | $80.1M | Hold |
8,002,700
| – | – | 0.02% | 324 |
|
2020
Q1 | $21.8M | Buy |
8,002,700
+1,210,000
| +18% | +$3.29M | 0.01% | 385 |
|
2019
Q4 | $8.15M | Hold |
6,792,700
| – | – | ﹤0.01% | 469 |
|
2019
Q3 | $10.3M | Hold |
6,792,700
| – | – | ﹤0.01% | 465 |
|
2019
Q2 | $27.3M | Hold |
6,792,700
| – | – | 0.01% | 403 |
|
2019
Q1 | $29.2M | Hold |
6,792,700
| – | – | 0.01% | 393 |
|
2018
Q4 | $39.1M | Hold |
6,792,700
| – | – | 0.01% | 367 |
|
2018
Q3 | $92.1M | Sell |
6,792,700
-394,000
| -5% | -$5.34M | 0.02% | 321 |
|
2018
Q2 | $85.3M | Buy |
7,186,700
+394,000
| +6% | +$4.68M | 0.02% | 315 |
|
2018
Q1 | $76.3M | Hold |
6,792,700
| – | – | 0.02% | 327 |
|
2017
Q4 | $45.4M | Hold |
6,792,700
| – | – | 0.01% | 360 |
|
2017
Q3 | $55.6M | Hold |
6,792,700
| – | – | 0.01% | 349 |
|
2017
Q2 | $30.5M | Hold |
6,792,700
| – | – | 0.01% | 382 |
|
2017
Q1 | $37.4M | Buy |
6,792,700
+2,312,214
| +52% | +$12.7M | 0.01% | 372 |
|
2016
Q4 | $18.1M | Sell |
4,480,486
-120,514
| -3% | -$488K | ﹤0.01% | 408 |
|
2016
Q3 | $32.4M | Hold |
4,601,000
| – | – | 0.01% | 372 |
|
2016
Q2 | $37.5M | Hold |
4,601,000
| – | – | 0.01% | 358 |
|
2016
Q1 | $37.4M | Hold |
4,601,000
| – | – | 0.01% | 358 |
|
2015
Q4 | $55.5M | Buy |
4,601,000
+2,887,082
| +168% | +$34.8M | 0.02% | 336 |
|
2015
Q3 | $20.5M | Buy |
1,713,918
+620,168
| +57% | +$7.42M | 0.01% | 422 |
|
2015
Q2 | $20M | Buy |
+1,093,750
| New | +$20M | 0.01% | 442 |
|